Table 3.
Variable | Adjustment | Death |
ESRDa |
||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P | SHR | 95% CI | P | ||
Age (per 10 years) | Model 1a | 2.05 | (1.49 to 2.82) | <0.001 | 0.87 | (0.64 to 1.18) | 0.364 |
Model 2a | 1.87 | (1.35 to 2.60) | <0.001 | 0.81 | (0.60 to 1.10) | 0.170 | |
Model 3a | 1.70 | (1.20 to 2.41) | 0.003 | 0.67 | (0.49 to 0.92) | 0.013 | |
Overt proteinuria | Model 1a | 1.38 | (0.78 to 2.45) | 0.270 | 6.03 | (2.73 to 13.3) | <0.001 |
Model 2a | 1.39 | (0.78 to 2.47) | 0.265 | 5.55 | (2.56 to 12.0) | <0.001 | |
Model 3a | 1.13 | (0.62 to 2.05) | 0.697 | 4.97 | (2.23 to 11.1) | <0.001 |
Model 1a: Overt proteinuria, sex, and estimated glomerular filtration ratio.
Model 1b: Age, sex, and estimated glomerular filtration ratio.
Model 2a/b: Model 1a/b + prior cardiovascular disease, diabetes and hypertension.
Model 3a/b: Model 2a/b + smoking history, hemoglobin and renin-angiotensin inhibitors.
Patients with stage 5 CKD were excluded.